Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2013 1
2018 1
2019 3
2020 3
2021 6
2022 6
2023 7
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical Trial.
He J, Chen J, Miao M, Zhang R, Cheng G, Wang Y, Feng R, Huang B, Luan H, Jia Y, Jin Y, Zhang X, Shao M, Wang Y, Zhang X, Li J, Zhao X, Wang H, Liu T, Xiao X, Zhang X, Su Y, Mu R, Ye H, Li R, Liu X, Liu Y, Li C, Liu H, Hu F, Guo J, Liu W, Zhang WB, Jacob A, Ambrus JL Jr, Ding C, Yu D, Sun X, Li Z. He J, et al. Among authors: shao m. JAMA Netw Open. 2022 Nov 1;5(11):e2241451. doi: 10.1001/jamanetworkopen.2022.41451. JAMA Netw Open. 2022. PMID: 36355371 Free PMC article. Clinical Trial.
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial.
He J, Zhang R, Shao M, Zhao X, Miao M, Chen J, Liu J, Zhang X, Zhang X, Jin Y, Wang Y, Zhang S, Zhu L, Jacob A, Jia R, You X, Li X, Li C, Zhou Y, Yang Y, Ye H, Liu Y, Su Y, Shen N, Alexander J, Guo J, Ambrus J, Lin X, Yu D, Sun X, Li Z. He J, et al. Among authors: shao m. Ann Rheum Dis. 2020 Jan;79(1):141-149. doi: 10.1136/annrheumdis-2019-215396. Epub 2019 Sep 19. Ann Rheum Dis. 2020. PMID: 31537547 Free PMC article. Clinical Trial.
Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial.
Zhang X, Miao M, Zhang R, Liu X, Zhao X, Shao M, Liu T, Jin Y, Chen J, Liu H, Zhang X, Li Y, Zhou Y, Yang Y, Li R, Yao H, Liu Y, Li C, Li Y, Ren L, Su Y, Sun X, He J, Li Z. Zhang X, et al. Among authors: shao m. Signal Transduct Target Ther. 2022 Mar 7;7(1):67. doi: 10.1038/s41392-022-00887-2. Signal Transduct Target Ther. 2022. PMID: 35250032 Free PMC article. Clinical Trial.
Mechanism of the Pulvinus-Driven Leaf Movement: An Overview.
Zeng F, Ma Z, Feng Y, Shao M, Li Y, Wang H, Yang S, Mao J, Chen B. Zeng F, et al. Among authors: shao m. Int J Mol Sci. 2024 Apr 23;25(9):4582. doi: 10.3390/ijms25094582. Int J Mol Sci. 2024. PMID: 38731801 Free PMC article. Review.
Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus.
Zhou P, Chen J, He J, Zheng T, Yunis J, Makota V, Alexandre YO, Gong F, Zhang X, Xie W, Li Y, Shao M, Zhu Y, Sinclair JE, Miao M, Chen Y, Short KR, Mueller SN, Sun X, Yu D, Li Z. Zhou P, et al. Among authors: shao m. PLoS Pathog. 2021 Oct 7;17(10):e1009858. doi: 10.1371/journal.ppat.1009858. eCollection 2021 Oct. PLoS Pathog. 2021. PMID: 34618873 Free PMC article.
Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world study.
Shao M, Miao M, Zhang X, Zhang X, An Y, Guo H, Lei L, Zhao Q, Ding Y, Lin J, Wu R, Yu F, Li Y, Miao H, Zhang L, Du Y, Jiao R, Pang L, Long L, Yao X, Shi X, Wang F, Cui L, Zhang L, Liu S, Lu F, Luo K, Zhao S, Wang Y, Wu X, Wang Q, Liu H, Song S, Zhou X, Zhang X, Shi S, Zhu H, Chen Y, Yu H, Wu J, Yu R, Fan W, Liu S, Xu J, Chen Z, Shi L, He J, Zhang X, Li Z, Li R. Shao M, et al. Lupus Sci Med. 2022 Nov;9(1):e000779. doi: 10.1136/lupus-2022-000779. Lupus Sci Med. 2022. PMID: 36351697 Free PMC article.
30 results